Ely Benaim, M.D., transitioned from Rexahn Pharmaceuticals to become the Chief Medical Officer (CMO) at Novocure in April 2019.
Ely Benaim, M.D., transitioned from Rexahn Pharmaceuticals to become the Chief Medical Officer (CMO) at Novocure in April 2019. At Novocure, he oversees clinical operations and medical affairs. Prior to joining Rexahn in 2015 as CMO, Benaim worked at Amgen, Millennium, and Sangamo.
Full founder directory · Investor directory · Company funding database · Fundraising library